Urology · Livonia, MI
NPI
1184688665
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
33014 5 Mile Rd
Livonia, MI, 48154
Phone (734) 261-7401
Groups this clinician bills Medicare through
Medicare paid, 2024
$324K
11,676 services
Medicare patients, 2024
766
Average age 74
Drug cost, 2024
$1.5M
4,494 prescriptions
Company payments, 2025
$1,801
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory V McIntosh was code 81003 (clinical chemistry), 999 times for 518 patients. In total Gregory V McIntosh billed 11,676 services in 106 codes, and Medicare paid $324K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 999 | 518 | $2.16 | $2,161 |
| 99214 Office E&M - Established | Office | 831 | 474 | $91.53 | $76K |
| 51798 Ultrasound - Nonspecific | Office | 498 | 333 | $8.41 | $4,190 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 410 | 288 | $12.62 | $5,173 |
| 84153 Clinical Chemistry | Office | 176 | 135 | $18.02 | $3,172 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 138 | 18 | $122.18 | $17K |
| 99213 Office E&M - Established | Office | 124 | 106 | $67.28 | $8,343 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 120 | 65 | $37.17 | $4,461 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 114 | 29 | $51.70 | $5,894 |
| 99232 Hospital E&M - Subsequent | Facility | 110 | 68 | $64.89 | $7,138 |
| 52000 Cystourethroscopy | Office | 99 | 75 | $175.15 | $17K |
| 96372 Injection Administration | Office | 78 | 25 | $9.58 | $747 |
| 99222 Hospital E&M - Initial | Facility | 59 | 56 | $107.38 | $6,336 |
| 80048 Clinical Chemistry | Office | 54 | 32 | $8.29 | $448 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 51 | 23 | $39.52 | $2,016 |
By year: 2022 $386K for 11,638 services; 2023 $366K for 13,415 services; 2024 $324K for 11,676 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 999 | 518 | $2.16 | $2,161 |
| 84153 Clinical Chemistry | 176 | 135 | $18.02 | $3,172 |
| 80048 Clinical Chemistry | 54 | 32 | $8.29 | $448 |
| 84403 Clinical Chemistry | 44 | 25 | $25.29 | $1,113 |
| 80076 Clinical Chemistry | 43 | 23 | $8.01 | $344 |
| 83735 Clinical Chemistry | 40 | 19 | $6.57 | $263 |
| 84100 Clinical Chemistry | 40 | 19 | $4.65 | $186 |
| 84154 Clinical Chemistry | 30 | 23 | $18.02 | $541 |
| 85025 Blood Count | 25 | 18 | $7.61 | $190 |
| 36415 Venipuncture Blood Collection | 14 | 13 | $8.65 | $121 |
Medicare prescription drug claims, 2024
In 2024, the drug Gregory V McIntosh prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,564 prescriptions and refills. In total Gregory V McIntosh wrote 4,494 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,564 | 3,737 | 454 | $30K |
| Finasteride Generic | 883 | 2,158 | 240 | $16K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 186 | 222 | 112 | $3,280 |
| Myrbetriq Mirabegron | 146 | 243 | 41 | $106K |
| Tolterodine Tartrate Generic | 111 | 185 | 32 | $6,558 |
| Gemtesa Vibegron | 107 | 171 | 24 | $83K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 102 | 204 | 24 | $1,986 |
| Abiraterone Acetate Generic | 84 | 84 | 11 | $145K |
| Solifenacin Succinate Generic | 79 | 180 | 30 | $4,358 |
| Dutasteride Generic | 75 | 211 | 25 | $2,518 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 72 | 72 | 58 | $243 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 72 | 166 | 18 | $2,206 |
| Oxybutynin Chloride Generic | 71 | 185 | 26 | $1,647 |
| Testosterone Generic | 69 | 73 | 11 | $4,596 |
| Prednisone Generic | 58 | 73 | 12 | $294 |
Brand drugs: - claims; generic drugs: 4,080 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory V McIntosh $1,801 ($1,801 in general payments such as food, travel and fees) from 20 companies. The largest payer was Janssen Biotech, Inc. with $227.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 7 | $227 |
| Sumitomo Pharma America, Inc. 4506.T | 12 | $196 |
| Biotissue Holdings Inc. | 2 | $191 |
| Dendreon Pharmaceuticals LLC | 2 | $150 |
| Pfizer Inc. PFE | 7 | $145 |
| Innovation Technologies Inc | 1 | $123 |
| Merck Sharp & Dohme LLC MRK | 4 | $115 |
| Myriad Genetic Laboratories, Inc. MYGN | 1 | $108 |
| Astellas Pharma US Inc 4503.T | 4 | $98.62 |
| Ferring Pharmaceuticals Inc. | 3 | $68.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.